Invitro & Invivo Diagnostic

Francis Medical Expands Commercial Use of Vanquish System for Prostate Tissue Ablation

Expansion of Vanquish procedures highlights growing adoption of minimally invasive water vapour ablation technology for prostate disease ...

Ribbon Bio Launches Cell-Free MiroSynth DNA and New In-Lab Cell-Free DNA Production Kit

Together, these announcements represent a step forward in increasing accessibility to complex DNA...

Illuminant Surgical Secures $8.4M to Advance Image-Guided Surgery with “X-Ray Vision” Technology

Funding to accelerate development of real-time imaging solutions aimed at improving surgical precision and patient outcomes...

Calidar Advances Breast Cancer Imaging with Completion of First-in-Human Study Enrollment for 4D Mammography System

Calidar completes enrollment in a first-in-human study of its 4D Mammography system, advancing a next-generation imaging platform designed to enhance breast cancer detection through molecular-level diagnostics....

The Neuron Clinic Expands Brain PET Capabilities with Additional NeuroLF Systems to Advance Alzheimer’s Diagnosis

Deployment of compact point-of-care brain PET scanners reflects growing demand for earlier, accessible neurodiagnostics in community settings...

How Inhaled Microplastics Impact Lung Function and Respiratory Health

The respiratory system has evolved efficient mechanisms to clear inhaled particles...

Non-Invasive Oncology Takes Center Stage at Sonire Therapeutics

The company is seeking to overcome long-standing limitations of conventional HIFU systems and expand the role of non-invasive therapies in clinical practice...

Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application

Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis...

Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows...

CStone Reveal Preclinical Data on Next-Generation ADCs Targeting EGFR/HER3 and Tumor Heterogeneity

CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate...